S. Sen Et Al. , "The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy," 43rd ERA-EDTA Congress , vol.21, Glasgow, United Kingdom, pp.53, 2006
Sen, S. Et Al. 2006. The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy. 43rd ERA-EDTA Congress , (Glasgow, United Kingdom), 53.
Sen, S., Ustundag, S., Gonlusen, G., Kanter, M., Dogutan, H., & Ciftci, S., (2006). The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy . 43rd ERA-EDTA Congress (pp.53). Glasgow, United Kingdom
Sen, Saniye Et Al. "The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy," 43rd ERA-EDTA Congress, Glasgow, United Kingdom, 2006
Sen, Saniye Et Al. "The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy." 43rd ERA-EDTA Congress , Glasgow, United Kingdom, pp.53, 2006
Sen, S. Et Al. (2006) . "The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy." 43rd ERA-EDTA Congress , Glasgow, United Kingdom, p.53.
@conferencepaper{conferencepaper, author={Saniye Sen Et Al. }, title={The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy}, congress name={43rd ERA-EDTA Congress}, city={Glasgow}, country={United Kingdom}, year={2006}, pages={53} }